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ABSTRACT
Accumulating evidence indicates that the intestinal microbiota regulates our
physiology and metabolism. Bacteria marketed as probiotics confer health beneﬁts
that may arise from their ability to aVect the microbiota. Here high-throughput
screening of the intestinal microbiota was carried out and integrated with serum
lipidomic proﬁling data to study the impact of probiotic intervention on the
intestinal ecosystem, and to explore the associations between the intestinal bacteria
and serum lipids. We performed a comprehensive intestinal microbiota analysis
using a phylogenetic microarray before and after Lactobacillus rhamnosus GG
intervention. While a speciﬁc increase in the L. rhamnosus-related bacteria was
observed during the intervention, no other changes in the composition or stability
of the microbiota were detected. After the intervention, lactobacilli returned to their
initiallevels.Aspreviouslyreported,alsotheserumlipidproﬁlesremainedunaltered
during the intervention. Based on a high-resolution microbiota analysis, intake
of L. rhamnosus GG did not modify the composition of the intestinal ecosystem
in healthy adults, indicating that probiotics confer their health eVects by other
mechanisms. The most prevailing association between the gut microbiota and
lipid proﬁles was a strong positive correlation between uncultured phylotypes of
Ruminococcus gnavus-group and polyunsaturated serum triglycerides of dietary
origin. Moreover, a positive correlation was detected between serum cholesterol and
Collinsella (Coriobacteriaceae). These associations identiﬁed with the spectrometric
lipidome proﬁling were corroborated by enzymatically determined cholesterol and
triglyceridelevels.Actinomycetaceaecorrelatednegativelywithtriglyceridesofhighly
unsaturated fatty acids while a set of Proteobacteria showed negative correlation
with ether phosphatidylcholines. Our results suggest that several members of the
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INTRODUCTION
Over 90% of the cells in the human body constitute microbes, the majority of them
living in the lower part of the gastrointestinal (GI) tract. Hence, we are composite
organisms programmed not only by the inherited and stable human genome but also
by the environmentally acquired and plastic microbiome. The coding capacity of the
microbiome vastly surpasses the human genome with more than three million genes
(Qin et al., 2010). While many of the microbial functions have not yet been characterized,
various mechanisms have been described by which the intestinal microbes impact our
life, including the metabolism of our food, exclusion of pathogens and many signaling
functions that range from modulation of the mucosal immune response to development
of metabolic diseases (Holmes et al., 2011; Sekirov, 2010). Bacterial metabolism of dietary
and endogenous substances is known to generate a wide repertoire of metabolites that
may have beneﬁcial or harmful eVects on the host (O’Keefe, 2008; Blaut & Clavel, 2007).
Hence,theintestinalmicrobiotahasaremarkablepotentialtoinﬂuencethephysiologyand
biology of the host (Tremaroli & B¨ ackhed, 2012), and unlike the human genome, its gene
pool can be modulated by changing the environmental conditions, such as food or drug
intake, aVecting the composition and function of the intestinal microbiota (Zoetendal,
Rajili´ c-Stojanovi´ c&deVos,2008).
Consumption of lactic acid bacteria marketed as probiotics is a common approach
to maintain health (Saxelin et al., 2005). Lactobacillus rhamnosus GG is one of the most
widely used probiotic bacteria that is assumed to interact with the host via binding to
human mucus via its extracellular pili (Kankainen et al., 2009). However, the further
molecular details of the probiotic signaling are not yet understood and it remains to be
established whether the eVect is direct, through metabolites or structural components
modulating for instance the immune responses of the host or indirect, via alteration
of the intestinal microbiota. From the ecological perspective, a single bacterial strain
is not likely to radically alter the established intestinal community, which in adults
typically consists of hundreds of diVerent species-level phylotypes that represent
approximately ten bacterial phyla, vastly dominated by Firmicutes, Bacteroidetes and
Actinobacteria,followedbyProteobacteria,FusobacteriaandVerrucomicrobia(Zoetendal,
Rajili´ c-Stojanovi´ c & de Vos, 2008). Many of the currently characterized phylotypes are
strict anaerobes, have not yet been cultured, and can only be recognized based on
molecular methods (Zoetendal, Rajili´ c-Stojanovi´ c & de Vos, 2008). The development of
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intestinal microbiota before and following probiotic intake. Targeted microbiota analyses
as well as the more recent community-level proﬁling studies support the view that the
eVects of probiotic intake are limited and only aVect bacteria related to the probiotics
(Satokarietal.,2001;Vaughan,Mollet&deVos,1999;Palaria,Johnson-Kanda&O’Sullivan,
2011;McNultyetal.,2011).
Animal and in vitro studies have shown that the intestinal microbiota can regulate
host lipid metabolism via numerous microbial activities (Fava, 2006; Martin et al., 2007).
The best characterized mechanism is through the biotransformation of bile acids, which
regulates the digestion and absorption of fats, and profoundly aVects the cholesterol
and other lipid metabolism in the body (G´ erard, 2010; Ridlon, Kang & Hylemon, 2006).
However, global monitoring of the serum and organ lipid proﬁles of germ-free and
conventionally raised mice suggests an even more widespread and profound inﬂuence
of the intestinal microbiota on host lipid metabolism, in particular on triglycerides and
phosphatidylcholines(Velagapudietal.,2010;Oreˇ siˇ c,H¨ anninen,&Vidal-Puig,2008).
In the present study, we characterized the impact of a probiotic intervention on the
composition and stability of the intestinal microbiota and serum lipid proﬁles in healthy
adults. A comprehensive intestinal microbiota proﬁling and phylogenetic analysis was
carried out with the Human Intestinal Tract Chip (HITChip), a phylogenetic microarray
that provides a robust and sensitive measurement platform to assessing the abundance
of over 1000 microbial species-like phylotypes representing the majority of the known
bacterial diversity of the human intestinal tract (Rajili´ c-Stojanovi´ c et al., 2009). Stability
of the microbiota was quantiﬁed by inter- and intra-individual correlations within
and between time points. The study subjects were sampled prior and after three weeks
consumption of dairy milks supplemented with either the probiotic L. rhamnosus GG or
a placebo. Moreover, the microbiota composition was analyzed from follow-up samples
collected three weeks after the intervention trial. With phylogenetic microarray analysis
we could both deepen and expand the typical bacterial analysis in probiotic trials, often
limitedtospeciﬁcbacterialgroups,suchaslacticacidbacteria,ortothedominantfraction
of the microbiota. Previously, we have shown that the intake of L. rhamnosus GG did not
elicitanysigniﬁcantchangesintheserumlipids(Kekkonenetal.,2008b).Thepresentstudy
complements these results by providing longitudinal data and evidence that the probiotic
intervention with L. rhamnosus GG does not aVect the overall composition or stability
of the intestinal microbiota. Furthermore, we have integrated the lipid proﬁling and
global microbiota data sets to investigate the overall associations between the intestinal
microbes and systemic metabolites, in particular serum lipids. Quantitative analyses
suggest that the abundance of speciﬁc intestinal microbes is correlated to that of speciﬁc
lipid species. We identiﬁed mainly uncultured members of the Firmicutes, Actinobacteria
and Proteobacteria that seem to be involved in the absorption and metabolism of the
dietary and endogenous lipids, providing a scientiﬁc rationale for further human studies
designedtoexploretheroleofintestinalmicrobesinlipidmetabolism,andassociationsto
health.
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Ethics statement
The trial and its protocol have been approved by the Ethics Committee of the Hospital
District of Helsinki and Uusimaa (Ethical protocol no HUS 357/E0/05). The subjects
providedwritteninformedconsent.Thedetailsofthistrialhavebeenpublishedpreviously
(Kekkonenetal.,2008a;Kekkonenetal.,2008b).
Subjects
The subjects were healthy Finnish adults (n D 25, 18 females, 7 males) with a mean
age of 42 years (23–55) and a mean BMI of 24 kg=m2 (18–30) from Helsinki region,
representingasubsetofalargercohort(Kekkonenetal.,2008a;Kekkonenetal.,2008b).The
CONSORTﬂowchart(Fig.1)summarizesthesubjectenrollment,interventionallocation,
follow-up, and data analysis during the study. The subject characteristics are provided in
SupplementalTableS1.
Dietary intervention
Thesubjectsconstitutedtwotreatmentgroupsinarandomized,doubleblindintervention
study to receive either L. rhamnosus GG (probiotic; n D 11) or placebo (n D 14). During
the intervention the subjects consumed daily a 250 mL milk-based fruit drink containing
either L. rhamnosus GG (ATCC 53103, 6.2 107 cfu/mL) or a similar placebo drink
without probiotic bacteria for three weeks. No other probiotic-containing products
were allowed three weeks prior or during the intervention; a list of fermented foods and
commercial probiotic-containing products was given to the subjects. The subjects were
notseparatelyquestionedabouttheirabstinencefromprobioticproducts,buttheyﬁlleda
studydiaryrecordingthedailyintakeofthestudyproduct.
Fecal samples and microbiota analysis with the HITChip and
quantitative PCR
Three fecal samples per individual were collected three weeks before, during and three
weeks after the intervention, as previously described (Kekkonen et al., 2008b). The fecal
DNA extraction with modiﬁed Promega method, and quantiﬁcation of the probiotic
counts with a strain-speciﬁc quantitative PCR (qPCR) assay have been described
previously (Ahlroos & Tynkkynen, 2009). The phylogenetic analysis of the intestinal
microbiota composition with the HITChip microarray was performed as previously
described (Rajili´ c-Stojanovi´ c et al., 2009; Salonen et al., 2010). The phylogenetic HITChip
microarray targets the V1 and V6 hypervariable regions of the 16S rRNA gene of over
1000 bacterial phylotypes that present the majority of the so far detected phylotypes
of the human intestine. Phylogenetic organization of the microarray probes and data
preprocessing have been explained in detail elsewhere (Rajili´ c-Stojanovi´ c et al., 2009;
Salonenetal.,2010;Jalanka-Tuovinenetal.,2011).QuantiﬁcationoftherelativediVerences
in the taxon abundance between samples was obtained by summarizing the probe signals
to phylotype (species-like), genus and phylum levels. Genus-level taxa with 90%
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sequence similarity in the 16S rRNA gene are referred to as Species and relatives, the latter
beingshortenedinthetextas“et rel.”(Rajili´ c-Stojanovi´ cetal.,2009).
Previously, HITChip-derived microbial proﬁles have been shown to correlate well
with those obtained with ﬂuorescence in situ hybridization (FISH) (Rajili´ c-Stojanovi´ c
et al., 2009) and pyrosequencing (Claesson et al., 2009). Samples were also used for
absolute quantiﬁcation of total bacteria, methanogenic Archaea, Lactobacillus group and
Biﬁdobacterium spp. with previously described qPCR primers and reaction conditions
(Salonenetal.,2010).
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Of the 25 study subjects used for the microbiota analysis, 22 (8 from probiotic group and
14fromplacebogroup)wereavailablefortheparallelanalysisofserumlipidproﬁlesbefore
andaftertheintervention(44samplesintotal).Venousbloodsamplesfromtheantecubital
vein were taken at baseline and after the three-week intervention. The blood samples
were stored at  20 C for further analyses. Total cholesterol, high-density lipoprotein
(HDL) and low-density lipoprotein (LDL) cholesterol as well as triglyceride levels were
enzymaticallydeterminedfromtheserumaspreviouslydescribed(Kekkonenetal.,2008a).
Global lipid proﬁling: sample preparation and analysis by
UPLC-MS
Extraction of lipids from the serum samples, analysis of the lipid extracts with Waters
Q-Tof Premier mass spectrometer combined with an Acquity Ultra Performance LCTM
(UPLC), data preprocessing and identiﬁcation of the lipid molecular species is described
in detail elsewhere (Kekkonen et al., 2008a). Lipids have been named according to Lipid
Maps (http://www.lipidmaps.org) with the following abbreviations: Cer: ceramide;
ChoE: cholesteryl ester; lysoPC: lysophosphatidylcholine; PA: phosphatidic acid; PG:
phosphatidylglycerol; PC: phosphatidylcholine; PS: phosphatidylserine; SM: sphin-
gomyelin; TG: triglyceride. Where the fatty acid composition could not be determined,
the total number of carbons and double bonds is indicated. The ﬁrst number indicates
the amount of carbon atoms in the fatty acid molecule, followed by the number of double
bonds.
Statistical analyses
The eVects of probiotic intervention on the intestinal microbiota were investigated with
a combination of linear models, sparse principal component analysis (PCA; Shen &
Huang, 2008; Lˆ e Cao, Gonz´ alez & D` ejean, 2009), unsupervised hierarchical clustering,
and signiﬁcance testing. The log-transformed HITChip and lipid proﬁling values were
approximately Gaussian distributed and fulﬁlled the general statistical assumptions
underlying the selected computational approaches. Background variables, including
age, body-mass index and gender were compared in the baseline samples to exclude
potentially confounding eVects associated with these variables. The Wilcoxon test was
used with continuous variables and the Fisher exact test for categorical variables, followed
byBenjamini–Hochbergp-valuecorrectionformultipletesting.NosigniﬁcantdiVerences
betweenthebackgroundvariableswereobservedbetweenthetreatmentgroups(p > 0:05
in all comparisons). The two-group comparisons between the time points and between
the treatment groups were quantiﬁed based on a linear model with group-wise ﬁxed
eVects and sample-speciﬁc random eVects, as implemented in the limma R package
(Smyth, 2004), to identify bacterial taxa with signiﬁcant changes induced by the probiotic
intervention and to assess the magnitude and signiﬁcance of the eVects. The function
lmFit was used to ﬁt the linear model, followed by signiﬁcance estimation by empirical
Bayes as described in Smyth (2004). In addition, power calculation was carried out to
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one signiﬁcant 2-fold alteration was inserted, and Gaussian noise was added using the
same average standard deviation as in the original data. Empirical power calculation with
1000 random permutations showed that 2-fold and higher alterations that follow the
noise levels in the original data were detected in >99.8% of the cases with sample size of
8 or more, based on the same detection criteria than in the current study, conﬁrming the
high statistical power of the analysis at the present sample size. PCA is a linear dimension
reduction method used to compress information in the high-dimensional phylogenetic
(genus-level) and lipid proﬁles into few informative features that capture the main
variation in the data and allow two-dimensional visualization of sample similarities. The
temporal and inter-individual similarity of the microbiota and lipid proﬁles was assessed
byaverageintra-andinter-individualPearsoncorrelations.r/betweenandwithinthetime
points,respectively.ThediVerencesinproﬁlesimilaritybetweentheprobioticandplacebo
groups were estimated with Wilcoxon test. The biweight midcorrelation, which is more
robust to outliers than the standard Pearson correlation, was used to quantify correlation
between the microbiota and lipid proﬁles across the individuals. High-throughput
screening studies involve considerable multiple testing and the traditional multiple
testing correction approaches are prohibitively conservative in this context due to their
emphasis on estimating the probability of a single false positive ﬁnding. Hence, we have
used q-values for multiple testing correction in the high-throughput screening tests that
includeparallelcomparisonsoflargenumbersoflipidsandbacterialphylotypes.
Correlation analysis of the intestinal microbiota and serum lipids
The biweight midcorrelation measure was used to quantify associations between the
microbiota and lipid proﬁling data sets, and between the microbiota and biochemically
determined lipids. The correlations between genus-level bacterial groups and lipid species
were calculated together with signiﬁcance estimates that were corrected for multiple
testing. The signiﬁcantly correlated (q < 0:05) phylotypes and lipids were selected for
further analysis. It is important to note, however, that while the present sample size
of 22 samples across 2 time points (before and during the probiotic intervention) is
suYcient for highlighting signiﬁcant correlation patterns, the present experimental
design cannot uncover causal relationships and the observed correlations may be partly
associated with diet or other confounding variables that simultaneously aVect both
lipid and microbiota proﬁles. Two-way average linkage hierarchical clustering of the
bacterial taxa and lipids was applied to highlight and visualize groups of phylotypes
and lipids sharing similar correlation patterns. Analogous ‘second-order’ correlations
have previously been applied for instance in the context of gene expression studies
(Parmigiani et al., 2004; Lahti et al., 2013). A constant plaid model biclustering was
used for systematic detection of signiﬁcantly correlated bacterial and lipid groups on
the correlation heatmap (Lazzeroni & Owen, 2002). To interpret the detected biclusters,
statistical enrichment (over-representation) of the implicated bacteria was quantiﬁed.
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the similarity (expressed as Pearson’s correlation) both within and between the time points (TP) for the
microbiota and lipid proﬁles by the average scatter r of the proﬁles. Lipid data is available for the ﬁrst two
timepoints(TP1andTP2,threeweeksbeforetheinterventionandduringtheintervention,respectively),
and not available ( ) for the third time point (TP3) measured three weeks after the intervention.
Betweensubjects Withinsubjects
Microbiota TP1 TP2 TP3 TP1 vs TP2 TP3 vs TP2
Probiotic 0.78 0.78 0.78 0.94 0.95
Placebo 0.76 0.77 0.77 0.94 0.95
Lipids
Probiotic 0.90 0.89 – 0.92 –
Placebo 0.91 0.89 – 0.93 –
Moreover, enrichment analysis was carried out for lipids containing even or odd number
of carbon atoms, as well as the enrichment of lipids with zero, one or more double bonds.
The enrichment analyses were carried out with Fisher’s exact test (Rivals et al., 2007). All
analyses were performed within the R statistical environment (R Development Core Team,
2010).
RESULTS
Impact of the L. rhamnosus GG intervention in the intestinal
microbiota
This study characterized the impact of L. rhamnosus GG intervention on the stability and
composition of the intestinal microbiota. The subjects in the probiotic group consumed
daily approximately 1010 (10:2log10) colony forming units (cfu) of L. rhamnosus GG.
The compliance was veriﬁed with the quantiﬁcation of L. rhamnosus GG in the feces with
strain-speciﬁcqPCR(Kekkonenetal.,2008b).TheaverageexcretionofL. rhamnosusGGin
the probiotic group was more than 1000-fold higher than that in the placebo group (8.52;
sd0:73log10 versus5.20;sd1:09log10 genomecopiespergramoffeces,respectively).
The stability of the microbiota during the trial was quantiﬁed by the similarity of the
microbiota proﬁles between the three time points with Pearson correlation (Table 1). The
average intra-individual correlations were high; 0.94–0.95 (sd 0.02–0.03). No signiﬁcant
diVerence in the temporal stability of the microbiota between the probiotic and placebo
groups was observed, indicating that the probiotic intervention did not alter the overall
microbialstability.PrincipalComponentAnalysis(PCA)visualizationoftherelationships
between the intestinal microbiota proﬁles (Fig. 2A) and hierarchical clustering (data not
shown) further supported the conclusion that there were no systematic diVerences in the
microbiota between the intervention groups. The average inter-individual microbiota
correlation was 0.76–0.78 with no signiﬁcant diVerences between the probiotic and
placebo groups (Table 1). The intra-individual microbiota correlations (r D 0:94–0.95)
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 8/25Figure 2 Intervention eVects on the abundance of L. rhamnosus. Mean abundance of L. rhamnosus
among the study subjects before, during and after the probiotic intervention (the time points 1–3,
respectively) quantiﬁed by the HITChip hybridization signal. The error bars denote the Gaussian 95%
conﬁdence limits based on standard deviation of the mean.
were notably higher than the inter-individual correlations (r D 0:76–0.78), stressing the
subject-speciﬁcityofthemicrobiota.
Linear models were used to quantify the eVects of the L. rhamnosus GG intervention
on individual taxa using genus- and phylotype-level microarray data. A speciﬁc and
transient increase of bacteria related to L. rhamnosus was detected in the probiotic group
immediately after the intervention (Fig. 2). There were no intervention-related eVects in
the other lactobacilli, Biﬁdobacteria or any other taxa either in the probiotic or placebo
group;howeversubstantialindividualvariationwasevident.
To complement the HITChip microarray analysis, we also determined the absolute
counts of total bacteria, methanogenic Archaea, Lactobacillus group and Biﬁdobacterium
spp. using real-time PCR. The ingestion of L. rhamnosus GG was reﬂected in the total
lactobacilli that showed a highly signiﬁcant increase in the probiotic group after the
intervention,returningtobaselinelevelsinthefollowup(q < 0:05inbothcomparisons).
No other signiﬁcant changes were observed in the amount of targeted microbes neither
in the probiotic or placebo group. We detected substantial inter- and intra-individual
variation in the methanogenic Archaea but that was independent of the time point or the
treatment group (data not shown). These observations support the conclusion that the
L. rhamnosusGGinterventiondidnotchangetheoverallmicrobiotacomposition.
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Global proﬁling of the serum lipids was performed using the UPLC-MS platform to
assess the serum lipid proﬁles at the molecular species level (Kekkonen et al., 2008a). In
total, 407 lipid species from 11 diVerent classes were identiﬁed. The lipid proﬁles were
dominated with triglycerides (TG; 37%), phosphatidylcholines (PC; 25%) and phos-
phatidyletanolamines (PE; 13%) while phosphatidic acids (PA), phosphatidylglycerols
(PG),sphingomyelins(SM),cholesterylesters(ChoE),lysophosphatidylcholines(lysoPC),
phosphatidylserines (PS), ceramides (Cer) and lysophosphatidylethanolamines (lysoPE)
eachcontributedwith7%to0.3%tothetotallipidpool.
The stability of the lipid proﬁles was quantiﬁed based on the same correlation analysis
approach than in the HITChip microbiota proﬁling analysis. No signiﬁcant diVerences
in the lipid proﬁle stability were observed between the treatment groups (average
intra-individual r D 0:92 and r D 0:93 for the probiotic and placebo groups, respectively;
Table 1). In contrast to microbiota proﬁles, the serum lipid proﬁles were remarkably
similarnotonlywithinthesubjectsbutalsobetweenthesubjects(averageinter-individual
r D 0:89–0.91; Table 1). No signiﬁcant diVerences were seen between the probiotic and
placebo groups, or between the time points. The stability of the lipid and microbiota
proﬁles showed a weak positive correlation (r D 0:27) across the subjects independent of
a treatment group. The global lipid proﬁles did not separate according to the treatment
group in PCA visualization (Fig. 2B), and no statistically signiﬁcant lipid alterations were
detected between the time points neither in the probiotic or placebo group (data not
shown; Kekkonen et al., 2008b). The fold-changes for each lipid species between the two
time points followed normal distribution in both intervention groups (data not shown),
which further supports the conclusion that the intervention did not induce systematic
alterationsonthelipidproﬁles.
Associations between the intestinal microbiota and serum lipids
In addition to studying the eVects of probiotic L. rhamnosus GG intervention in the
intestinal microbiota, we investigated the co-variation of the microbiota and serum
lipid proﬁles. As discussed above, our results (Table 1, Fig. 2) conclusively show that the
probiotic intervention did not aVect the lipid proﬁles or the microbiota beyond the L.
rhamnosus that was ingested. Hence, the subjects from probiotic and placebo groups
were pooled to increase the sample size and statistical power in exploring the associations
betweentheintestinalmicrobiotaandserumlipids.
Heatmap visualization of the microbiota–lipid correlations across the 22 subjects
from 2 time points revealed intestinal bacteria and serum lipids with signiﬁcantly
correlatedabundancepatterns(Fig.3).Intotal,86bacterialgroup-lipidpairswithnotable
correlations(0:5orhigher)wereidentiﬁedatq < 0:05signiﬁcancelevel(Fig.3).Among
the signiﬁcant correlations, 23 of the 131 genus-level taxa detectable by the HITChip were
represented (Supplemental Table S3). Most of these taxa belonged to Proteobacteria (6)
and Firmicutes within Clostridium cluster XIVa (5) and Bacilli (3). From the lipid side,
the vast majority of the signiﬁcant correlations were attributable to the most dominant
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correlations were strongly dominated by the positive correlations between bacteria
related to Ruminococcus gnavus and diVerent TG species (31 of 40 signiﬁcant positive
correlations, average r D 0:61; Fig. 3A). Detailed analysis at the phylotype-level data
indicated that within the R. gnavus group, two uncultured phylotypes, uncultured human
gut bacterium JW1G3 and JW1H4a, dominated the correlations while the type species
R. gnavus or related R. torques did not correlate signiﬁcantly with TG or any other lipid
species. Other representatives of the Clostridium cluster XIVa included bacteria related to
Dorea formicigenerans that also correlated positively with four TG species (Fig. 3; average
r D 0:58). The remaining TG correlations were negative and involved phylogenetically
diversebacteria(SupplementalTableS3).AlsoPCscorrelatedsigniﬁcantlywithnumerous
taxa, most of which correlated negatively with ester- or ether linked PCs. Interestingly,
a set of Proteobacteria (Campylobacter, Helicobacter and Moraxellaceae) with low signal
intensities had a clear negative correlation with PC. Similarly, two Lactobacillus species
(L. rhamnosus that was ingested during the trial and L. salivarius) together with another
group of Bacillus, Enterococcus spp., also correlated negatively with PC while few Firmi-
cutesexhibitedapositivecorrelationwiththislipidspecies.Amongthelessabundantlipids
(<10%ofthetotallipidpool),apositivecorrelationwasdetectedbetweencholesterylester
and Collinsella (r D 0:59; Supplemental Table S3, Fig. 5A). On the phylotype level, the
correlation was mainly attributable to an uncultured bacterium clone Eldhufec074 within
genus Collinsella. Another group of Actinobacteria, namely Actinomycetaceae, showed a
signiﬁcantnegativecorrelationtoTGandPA.
Hierarchical clustering and heatmap visualization of the signiﬁcantly correlated
lipid–bacteria pairs revealed groups of lipids and bacteria sharing similar correlation pat-
terns.Aconstantplaidmodelbiclusteringapproachwasappliedtodetectcoherentgroups
of signiﬁcantly correlating microbe–lipid pairs (see Methods). The analysis revealed three
major clusters of signiﬁcantly correlated lipid–microbe pairs (Supplemental Table S2).
One of the observed biclusters highlights the above discussed positive association
between bacteria related to R. gnavus and TGs. Another TG cluster, containing highly
unsaturated long-chain fatty acids, consisted of negatively correlating bacteria related to
Megamonas hypermegale (family Veillonellaceae, Clostridium cluster IX) or belonging to
the Actinomycetaceae. The third cluster contained a set of Proteobacteria (Helicobacter,
Oceanospirillum and Moraxellaceae spp.) and bacteria related to Eubacterium cylindroides
withinthefamilyErysipelotrichaceae,whichallcorrelatednegativelywithetherlipids.
To explore the nature of the identiﬁed lipid–microbe pairs, we quantiﬁed the
enrichmentofspeciﬁc,functionallyrelevantlipidcategoriesinthebiclusters.Inparticular,
we investigated the enrichment of lipids with even and odd number of carbon atoms and
the degree of saturation (0, 1, or more double bonds). The origin of lipid can be inferred
fromitschemicalcomposition:Polyunsaturatedfattyacids(PUFAs;morethanonedouble
bond)andlipidsthathaveunevennumberofcarbonatomsoriginatefromplants,bacteria
or marine organism as humans cannot synthesize them. Signiﬁcant enrichment of long
acylchain(p < 0:05;Fisherexacttest)wasdetectedamongtheTGlipidsthatsigniﬁcantly
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 11/25Figure 3 Correlations between intestinal genus-level phylogenetic groups and serum lipids. The correlations between the intestinal bacteria
and serum lipids are indicated by colors (red: positive; blue: negative). The signiﬁcant correlations (q < 0:05) are indicated by ‘C’; only lipids
and bacteria with at least one signiﬁcant correlation are shown. Hierarchical clustering of the rows and columns highlights groups of signiﬁcantly
correlated bacteria and lipids. Lipids have been named according to Lipid Maps (http://www.lipidmaps.org) with the following abbreviations: Cer:
ceramide; ChoE: cholesteryl ester; lysoPC: lysophosphatidylcholine; PA: phosphatidic acid; PG: phosphatidylglycerol; PC: phosphatidylcholine; PS:
phosphatidylserine; SM: sphingomyelin; TG: triglyceride. Where the fatty acid composition could not be determined, the total number of carbons
and double bonds is indicated. The ﬁrst number indicates the amount of carbon atoms in the fatty acid molecule, followed by the number of double
bonds. For further details, see the Methods section.
correlated with bacteria related to R. gnavus (Supplemental Fig. S1; Supplemental Table
S2). Such a positive association suggests a role for these R. gnavus-related bacteria in the
absorption of dietary lipids. In support of this interpretation, TGs containing fatty acids
with odd number of carbons were also relatively common in this group (p D 0:1). In the
other two biclusters, no signiﬁcant enrichment of odd/even carbon count or saturation
level was detected but within the bicluster 2 (Supplemental Table S2), Actinomycetaceae
correlatedexclusivelywithhighlyunsaturatedPUFAs(Fig.3).
Associations between the intestinal microbiota and biochemically
determined serum lipids
The mean values (SD) for the major serum lipids were total cholesterol 5.10 (1.02), LDL
cholesterol3.00(1.21),HDLcholesterol1.50(0.33)andTG1.20(0.71)mmol/L(Kekkonen
et al., 2008a). No signiﬁcant changes were detected in the lipids of the probiotic or the
placebo groups during the intervention (Kekkonen et al., 2008b). Hence, we analyzed
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 12/25Figure 4 Association between Ruminococcus gnavus et rel. and serum triglyceride (TG) lipids. The
relative amounts of R. gnavus et rel. were quantiﬁed by the HITChip analysis and the triglyceride
concentration was determined based on two independent techniques: A the triglyceride TG(54:5) (see
Fig. 3 for explanation) by mass spectrometry (r D 0:61); B triglyceride by an enzymatic assay (r D 0:60).
the potential associations of the enzymatically determined major blood lipids with the
intestinalmicrobiota(Table2).ApositivecorrelationbetweenbacteriarelatedtoR. gnavus
andTGwasobserved(q < 0:01;r D 0:60;Fig.4B),corroboratingtheassociationidentiﬁed
withinthegloballipidanalysis.Inlinewiththespectroscopiclipidanalysis,representatives
of Bacteroidetes and Uncultured Clostridiales correlated negatively and other implicated
Firmicutes positively with enzymatically determined TG (Table 2). Representatives of
Proteobacteria and Actinobacteria that correlated negatively with TG in the lipid proﬁling
datadidnotcorrelatesigniﬁcantlywithenzymaticallydeterminedTG.Suchinconsistency
maypartlyarisefrommethodologicalreasonsastheenzymaticassaycapturesnotonlyTG
butalsodiacylglyceride,monoacylglycerideandfreeglycerol,whilelipidproﬁlingcaptures
TGsatthemolecularlevel.
Collinsella spp. and Eubacterium biforme et rel. showed statistically signiﬁcant (q <
0:05) and positive correlations to enzymatically determined total and LDL cholesterol
(Fig.5B;SupplementalTableS2).Noothersigniﬁcantcorrelationswereidentiﬁedfortotal
or LDL cholesterol while HDL cholesterol correlated signiﬁcantly with numerous taxa.
Eight diVerent Firmicutes including taxa related to Ruminococcus obeum and D. formici-
generanswerefoundtocorrelatenegativelywithHDL,whileUnculturedClostridialesIwas
theonlytaxonshowingpositivecorrelationtoHDL(SupplementalTableS2).
DISCUSSION
In the present study, we analyzed the eVect of probiotic intake on the stability and
composition of the intestinal microbiota and of the serum lipids, and the overall
associations between the microbiota and lipid proﬁles. The microbiota was analyzed
using the HITChip, a phylogenetic microarray, providing one of the ﬁrst holistic
and community-level microbiota assessments after a probiotic intervention. The data
published so far is largely dominated with targeted microbiota analyses that have
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 13/25Table 2 Associations between genus-level bacterial groups and enzymatically determined lipids. As-
sociations between the relative amounts of genus-level bacterial groups as determined by the HITChip
analysis and the serum lipid concentrations are quantiﬁed with a biweight midcorrelation. Only signiﬁ-
cant positive and negative correlations are shown (q < 0:05; otherwise ‘ ’). Abbreviations: Total choles-
terol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, triglyceride
(TG). Correlations between genus-level bacterial groups and mass spectrometry-determined lipids are
provided in Supplemental Table S3.
Phyla/Firmicuteorder Genus-leveltaxon TC LDL HDL TG
Actinobacteria Collinsella 0.56 0.57 – –
Bacilli Aneurinibacillus – –  0.58 0.50
Bacteroidetes Bacteroides plebeius et rel. – – –  0.47
Bacteroidetes Bacteroides vulgatus et rel. – – –  0.47
Bacteroidetes Tannerella et rel. – – –  0.45
Clostridium cluster XI Anaerovorax odorimutans et rel. – –  0.48 0.49
Clostridium cluster XIVa Clostridium nexile et rel. – –  0.45 –
Clostridium cluster XIVa Clostridium sphenoides et rel. – – – 0.46
Clostridium cluster XIVa Dorea formicigenerans et rel. – –  0.56 0.57
Clostridium cluster XIVa Eubacterium hallii et rel. – – – 0.47
Clostridium cluster XIVa Ruminococcus gnavus et rel. – –  0.46 0.60
Clostridium cluster XIVa Ruminococcus obeum et rel. – –  0.48 0.51
Clostridium cluster XV Anaerofustis – –  0.45 –
Clostridium cluster XVI Eubacterium biforme et rel. 0.48 0.47 – –
Clostridium cluster XVI Eubacterium cylindroides et rel. – –  0.45 –
Uncultured Clostridiales Uncultured Clostridiales I – – 0.53  0.45
Uncultured Clostridiales Uncultured Clostridiales II – – –  0.54
Figure 5 Association between Collinsella spp. and serum cholesterol. The relative amounts of
Collinsella spp. were quantiﬁed by the HITChip analysis, and serum cholesterol levels were determined
by two independent techniques: A Cholesterol ester ChoE(20:5) (see Fig. 3 for explanation) by mass
spectrometry (r D 0:59); B low-density lipoprotein (LDL) cholesterol by enzymatic assay (r D 0:57).
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 14/25reported a generic increase of lactic acid bacteria after intake of individual lactobacilli
strains (McNulty et al., 2011; Palaria, Johnson-Kanda & O’Sullivan, 2011; Satokari et
al., 2001; Savard et al., 2011; Vaughan, Mollet & de Vos, 1999; Yamanoa et al., 2006).
Our community-level analysis showed that the probiotic intake did not introduce any
changes in the microbiota composition or stability except the speciﬁc increase of L.
rhamnosus and total lactobacilli, which likely reﬂected the excretion of the ingested strain.
Similarly, ingestion of a mixture of ﬁve diVerent probiotic strains did not induce any
signiﬁcant changes in the microbiota composition neither in adults nor in simpliﬁed
model community in mice (McNulty et al., 2011). Even when a combination of probiotic
and prebiotic (synbiotic) food was consumed, two studies based on microbiota proﬁling
andqPCRdidnotidentifyanydiVerencesinthemicrobiotacompositionbetweenplacebo
and treatment besides the ingested strains (Palaria, Johnson-Kanda & O’Sullivan, 2011;
Vitalietal.,2010).
WehaveshownpreviouslyusingthesamecohortthattheingestionofL. rhamnosusGG
had apparent eVects on the host immunology (Kekkonen et al., 2008b). Hence, our results
does not support the hypothesis that probiotic bacteria would modulate the endogenous
microbiota but rather points towards direct signaling to host or altered gene expression of
theresidentmicrobiotaasamodeofprobioticactionasrecentlyproposed(McNultyetal.,
2011).
Our study was carried out in healthy adults with seemingly well-established and
balanced microbial communities. In subjects whose intestinal ecosystem is unbalanced
e.g.duetopathogenovergrowth,gastrointestinalsymptomsorrecentintakeofantibiotics,
intake of probiotic bacteria may modulate the microbiota. Similarly, the developing
microbiota of children is potentially more susceptible to environmental modulators
including probiotics. Although substantial changes in infant microbiota following daily
intakeofL. rhamnosusGGhaveindeedbeenreported(Coxetal.,2010),theseresultsmust
be interpreted with caution as the phylogenetic microarray used in that study provided
signals for close to 50 phyla (Midgley et al., 2012) whereas the human intestinal ecosystem
onlycontainsamaximumof10phyla(Rajili´ c-Stojanovi´ c,Smidt&deVos,2007).
To the best of our knowledge, this cohort is the ﬁrst addressing the potential impact of
probiotics on global serum lipid proﬁles in adults. Daily intake of L. rhamnosus GG for
three weeks did not introduce any consistent alterations in the serum lipids or in the bio-
chemically determined cholesterol and triglyceride levels of the healthy, normolipidemic
adults analyzed in this and previous study (Kekkonen et al., 2008a). Probiotic bacteria
have been suggested as a potential non-drug treatment to lower serum cholesterol levels
based on their in vitro described ability to deconjugate bile acids and directly assimilate
cholesterol. A recent meta-analysis implies that probiotic intake can lower the total and
LDL cholesterol (Guo et al., 2011), although numerous human studies have failed to
observeanyeVectsonserumlipidsafterprobioticintake(seee.g.Sadrzadeh-Yeganehetal.,
2010; Pereira & Gibson, 2002). One explanation for the controversy is that similarly to the
strain-speciﬁcity of the immunomodulatory eVects of probiotics (Kekkonen et al., 2008b),
also their eVects on lipid metabolism are likely to vary between diVerent strains. In atopic
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 15/25infants the consumption of L. rhamnosus GG supplemented formulas for several months
resulted in a reduced proportion of -linolenic acid and of total n-3 PUFAs, leading to
increased n-6 to n-3 PUFA ratio in sera of probiotic-fed infants (Kankaanp¨ a¨ a et al., 2002).
Decrease of n-3 fatty acids has negative health implication, underlining the need for more
in vivo research to specify the bacterial strains and target population where probiotics can
havebeneﬁcialeVectsonthehostlipidmetabolism.
Our data indicates that the variation of the intestinal microbiota is considerably higher
across the individuals than the variation in serum lipid proﬁles, highlighting the tight
homeostatic control of systemically circulating lipids. The intestinal microbiota is known
to play an important role in the regulation of systemic lipid metabolism (Martin et al.,
2007;Velagapudietal.,2010).Inthisstudy,weidentiﬁedseveralnovelassociationsbetween
the human intestinal commensals and serum lipids. From the lipid side, TGs (62%)
and PCs (30%) dominated the signiﬁcant lipid–microbe correlations. TGs are used for
energy storage while PCs are abundant constituents of cell membranes. Both of these
abundantlipidclasseswereaVecteduponcolonizationofgerm-freemice(Velagapudietal.,
2010). The most prominent correlation was between TGs and uncultured phylotypes
related to R. gnavus that belong to family Ruminococcaceae in Clostridium cluster
XIVa. Two characterized species within the group, R. gnavus and R. torques, have been
implicated in intestinal disorders as they appeared to be overrepresented both in IBS
(Kassinen et al., 2007; Rajili´ c-Stojanovi´ c et al., 2011) and in IBD (Joossens et al., 2011;
Prindiville, Cantrell & Wilson, 2004). The TG lipids that were positively associated with
R. gnavus-related phylotypes were enriched with polyunsaturated and odd-chain fatty
acids. Since the odd-chain fatty acids are not synthesized in the body, these positive asso-
ciations suggest that the implicated bacteria facilitate the absorption of polyunsaturated
dietary lipids. Moreover, it cannot be excluded that these bacteria are even involved
in their biosynthesis as related R. obeum together with other Firmicutes are among
the intestinal bacteria capable of producing isomers of conjugated linoleic acids (CLA;
McIntoshetal.,2009).
Triglycerides carry diVerent types of fatty acids, and accordingly not all TGs displayed
the same pattern regarding microbial correlations. For example, bacteria related to D.
formicigenerans showed positive association to saturated triglycerides with a small carbon
number, i.e. including palmitic acid. These fatty acids are mainly produced de novo in the
liver (Westerbacka et al., 2010; Kotronen et al., 2009). D. formicigenerans produces formate
andacetatethatareprecursorsofhepaticlipogenesis.Recentmetaproteomicworkveriﬁes
thattheacetatekinasesinvolvedinacetateproductionarehighlyexpressedintheintestinal
ecosystem (Kolmeder et al., 2012), suggesting that several intestinal bacteria have potential
toregulatelipogenesis.Ontheotherhand,Actinomycetaceaewereinverselyassociatedwith
TGs containing highly unsaturated triglycerides with a high carbon number. Such TGs
carryphysiologicallyimportantfattyacidssuchasC22:6(docosahexanoicacid)andC20:4
(arachidonic acid). Both are important cell membrane components, the former especially
invisualandneuraltissues,andthelatterisinvolvedininﬂammatorysignaling.Whilenot
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formsoftheseActinobacteriaareabundantintheoralcavity.
We identiﬁed multiple taxa correlating negatively with normal or ether linked forms of
PC.DietaryPCwasrecentlyidentiﬁedascompoundthatafterconversionbytheintestinal
microbiota promotes heart disease (Wang et al., 2011). Unfortunately, that study did
not address the identity of bacteria involved in the metabolism of dietary PC, but our
data suggest that diVerent Firmicutes, Proteobacteria and Fusobacteria may participate
in this metabolic conversion (Fig. 3). Remarkably, the presence of serum ether PCs was
negatively associated with various taxa, mainly with Gram-negative genera that include
pathogens and commensals, such as Helicobacter, Moraxellaceae and Campylobacter.
Among the ether lipids, plasmalogens, known as endogenous antioxidants (Wallner &
Schmitz, 2011), are the most abundant. Their negative association with Proteobacteria
couldindicatethattheimplicatedbacteriamayinduceoxidativestressinhostcells,leading
to depletion of plasmalogens. In support of this hypothesis, lipopolysaccharide (LPS), a
ubiquitous and toxic surface component of Gram-negative bacteria, induces oxidative
stressinmammaliancellcultures(Aly,Lightfoot&El-Shemy,2010).
Finally, we identiﬁed positive correlation between the abundance of serum cholesterol
and genus Collinsella (Actinobacteria, family Coriobacteriacea). Biochemical lipid analysis
indicated that Collinsella spp. together with bacteria related to E. biforme correlated
speciﬁcally with total cholesterol and LDL but not HDL. To our knowledge, our work
provides the ﬁrst in vivo evidence about the implication of Coriobacteriacea in human
lipid metabolism. Our present ﬁndings are supported by the data generated with rodent
models. In a hamster model, the proportion of Coriobacteriaceae showed high positive
correlation with non-HDL plasma cholesterol levels and reacted to the intake of dietary
lipids (Martinez et al., 2009). In a mouse model, a strong positive correlation between
Coriobacteriaceae and hepatic triglycerides was identiﬁed (Claus et al., 2011), providing
cumulative indication for the involvement of Coriobacteriaceae in mammalian lipid
metabolism. While only one taxon (Collinsella) correlated statistically signiﬁcantly with
cholesterolinthelipidproﬁlingdata,numeroustaxashowedsigniﬁcantcorrelationtoen-
zymatically determined HDL cholesterol. This may arise from technical diVerences, as the
lipid proﬁling does not quantify free cholesterol but its derivative cholesteryl ester, where
cholesterol is esteriﬁed to long-chain fatty acids. All taxa that were associated with both
HDL cholesterol and TG had opposite correlation with these lipids (Supplemental Table
S2), inaccordance with the factthat serum TG andHDL show strong inverserelationship,
and their ratio is used as an atherogenic index that predicts cardiovascular risk (Jeppesen
et al., 1997). Hence, identiﬁcation of bacteria that potentially aVect the athreogenic index
mayprovideimportantclinicalimplicationsfordyslipidemicindividuals.
While good correspondence between the HITChip and pyrosequencing studies
have been previously demonstrated, the main advantage of the HITChip microarray
compared to the pyrosequencing studies is that the microarray technology provides
very standardized and cost-eYcient tools for deep and reproducible analysis of intestinal
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al.,2009;Salonenetal.,2012).Weexpectthatourmajorﬁndings,theassociationsbetween
speciﬁc lipid species and bacteria related to Collinsella or R. gnavus could be detected
also in a standard pyrosequencing study due to the relatively high abundance of these
organisms.However,theassociationsinvolvinglessabundanttaxa(Bacilli,Proteobacteria,
Actinomycetaeae)wouldlikelyhavebeenmissedwithconventionalsequencingdepth.
In summary, quantitative analysis of high-throughput proﬁling data identiﬁed several
signiﬁcant correlations between the intestinal microbiota and serum lipids. These
results partly conﬁrm and extend previous observations in animal studies, and provide
hypotheses for follow-up studies in humans. It is important to note, however, that the
present analysis is based on a Finnish cohort and only two time points, and does not
considercausalrelationshipsbetweenthesevariables.Thereforeitcannotbeexcludedthat
some of the observed correlations may be associated with the diet or other confounding
variables that simultaneously aVect both lipid and microbiota proﬁles. However, as all
subjects ate their habitual diets, individual food components are not likely to cause
systematic bias to the observed lipid–microbe correlations, which is further supported
by the observation of distinct groups of correlated lipid–microbe pairs in the bicluster
analysis. It can also be ruled out that the intervention would have caused the correlations
as control measurements from the baseline were included, the ingested probiotics
L. rhamnosus GG did not correlate signiﬁcantly with any serum lipid, and the drink did
nototherwisealterthemicrobiota.Conﬁrmationoftheﬁndingsinanindependentcohort
and a more thorough longitudinal analysis will be necessary to assess the eVect of external
variables on the microbiota–lipid correlations and their potential causal associations.
Noneoftheimplicatedbacterialtaxaarefunctionallycharacterized,andthusthepotential
mechanisms of how human intestinal bacteria relate to the host lipid metabolism are
currently unknown. Among the potential mechanisms, bacterial modiﬁcation of the
bile acid pool is by far the best characterized. Collinsella spp., R. gnavus as well as the
genus Eubacterium are among the intestinal bacteria capable of deconjugating bile acids
(Lepercq et al., 2004). Bile acids are cholesterol-derived detergents that play a central role
in the absorption of fat in the intestine but also in signaling with systemic endocrine
functions (Swann et al., 2011). It has been known for long that intestinal bacteria can
chemically modify bile acids but recent work suggest that the microbiota may also control
their production and degradation (Antunes et al., 2011). In mice the intestinal bacteria
profoundly aVect the emulsiﬁcation, absorption and transport of dietary fat as well as
theirstorageandperoxidationthroughthemetabolicandsignalingpropertiesofbileacids
(Martinetal.,2007).
CONCLUSION
Ourdatasupportstheconceptthattheoveralllipidcontentinhumanserumisacomposite
of host and microbial metabolic activity, and the intestinal commensals are implicated
in the metabolism of various lipid species that human body utilizes for membranes,
energy storage and signaling. Considering that a single gene in an intestinal bacterium
Lahti et al. (2013), PeerJ, DOI 10.7717/peerj.32 18/25could alter host fatty acid composition (Rosberg-Cody et al., 2011), we can only envisage
the metabolic capacity and the functional consequences from the million genes in the
intestinal microbiome. As epidemiological data do not support a link between dietary
cholesterol and serum cholesterol levels (Lecerf & de Lorgeril, 2011), the role of genetic
factors in the individual variability of cholesterol levels is evident. Identiﬁcation of the
bacteria and their mechanisms that regulate host fatty acid and lipid metabolism have
considerablepotentialforclinicalimplicationsduetotheprofoundroleofthesemolecules
for instance in cardiovascular disease and regulation of inﬂammatory cytokine signaling
(Calder, 2011). Future trials involving controlled diet and dyslipidemic individuals will
providefurtherinsightsontheroleofintestinalmicrobesonhumanlipidmetabolism.
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